After Doctors Deemed Her Treatment 'Non-Urgent,' 29-Year-Old Woman Receives Unexpected, Life-Threatening Diagnosis
"The first thing I said to [my surgeon] was, 'Am I going to die?' to which he said, 'Look, I hope not,' " Graham recalled about learning of her diagnosis
After undergoing chemotherapy and having part of her colon removed, Graham is currently cancer-free, but she remains in a five-year period of surveillanceThe first question that Sarah Graham recalled asking her doctor after being diagnosed with stage 3 bowel cancer days following her 29th birthday was, "Am I going to die?"
Her diagnosis came in 2024 after she went to the doctor to discuss a variety of symptoms, including an approximately 44-lb weight gain, extreme pain when going to the bathroom, and blood in her stool. That July, her general practitioner sent her for a stool test, which came back inconclusive, she told Australian news outlet Mamamia.
A colonoscopy was recommended, but Graham learned that it had been deemed "non-urgent," meaning that she was unable to schedule it until November.
The Australian interior designer's symptoms continued, and she told the outlet that she decided to get a second opinion. This led to her receiving a diagnosis that is becoming more prevalent among people her age.
"I explained my symptoms again to her, and said, 'Look, [the blood] is happening almost every time I go to the bathroom now. I'm getting really scared to go to the bathroom,' " she recalled.
Graham, who became lactose intolerant at 22 and was diagnosed and treated for endometriosis at 26, said that doctors initially thought that she had "something like Crohn's or Irritable Bowel Syndrome (IBS)."
She said that they told her she was "way too young for bowel cancer."
However, after undergoing a "traumatic" colonoscopy, Graham said that nurses seemed to be giving her a wide berth in the recovery room.
"It was getting to 6 p.m. ... and I was the only one in the recovery room," she said, adding, "And, for some reason, none of the nurses were stopping to talk to me. They were all staring at a distance."
Her mom was brought back, and the surgeon finally told her that they had found a mass.
Graham was told that she needed "to move quickly" to receive treatment and was scheduled for an "urgent CT scan," with the doctor saying that the mass was "likely malignant."
After undergoing additional testing, she was diagnosed with stage 3 bowel cancer."I knew something was wrong [but] I never expected this. I felt let down, I think," she admitted. "I know my body, and I knew what I was living with and no one would listen."
Referring to the original doctor, who believed she might be suffering from hemorrhoids or a fissure, Graham wondered "what would've happened" had she waited until November to undergo her colonoscopy.
Graham had part of her colon removed and went through six months of chemotherapy.
After treatment, she said that she is undergoing surveillance for five years. However, her outlook is "good" at the moment.
"They've put me in a low risk of recurrence category but, of course, there is no life free of the burden of cancer, unfortunately," she explained.
Now, the designer is sharing a lesson that she hopes others will learn from.
"The best piece of advice I was given is that if your doctor says no to something you request, ask them to write that down. You will quickly realize that if they don't want to put their name to denying you something, and something happens later, they don't want to be liable for it," she said, adding, "If anything is out of the ordinary, you need to get it checked."
In 2025, the American Cancer Society noted that people under the age of 50 are increasingly being diagnosed with colorectal cancer. The diagnosis is also slightly more deadly than it was in the past.
The reason for the diagnosis becoming more prevalent is unclear. However, a study published in April 2025 suggested that there might be a link between children under 10 being exposed to a bacteria in some strains of E. coli. Another 2022 study links colorectal cancer and the rise in ultra-processed foods; however, this is generally in men.
Read the original article on People

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
CSL to separate vaccine business, cut jobs
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Dive Brief: Australian drugmaker CSL is separating its vaccine business, Seqirus, into a standalone company as part of a sweeping restructuring across its business that will involve workforce cuts of up to 15%. CSL said Tuesday that a separated Seqirus, which will be chaired by former unit president Gordon Naylor, 'will allow autonomy to set an independent strategic direction, including capitalizing on potential opportunities that may arise in a highly dynamic vaccines market.' The de-merger is expected to be completed by June next year. In earnings also released Tuesday, CSL said revenue for its vaccine unit was up 2%, which CEO Paul McKenzie described during a conference call as 'robust result' given lower influenza vaccination rates in the U.S. The lower rates resulted in 'competitive pressure' in the market, he added. Dive Insight: Most of CSL's revenue comes from its CSL Behring business, which sells a range of blood disease treatments. Through Seqirus, however, CSL is also known for seasonal influenza vaccines like Afluria and Flucelvax that it sells worldwide. The company said vaccines contributed $2.2 billion to total revenue of $15.6 billion for the fiscal year ending June 30, which saw a 14% increase in adjusted net profit. While vaccine revenue was up slightly, CEO McKenzie said during the earnings call that the weak market was 'disappointing.' 'We view the softness in the U.S. seasonal category as highly irrational based on the vaccine risk-reward profiles and the scale of disease burden, which this year reached a 15-year high,' he added. Vaccines have become a flash point in the U.S. as Health and Human Services Secretary Robert F. Kennedy Jr. applies more scrutiny to established shots and policy. Most recently, HHS said it would defund research and development related to messenger RNA-based vaccines, canceling $500 million worth of contracts, including one with CSL Seqirus. In 2022, CSL Seqirus licensed mRNA technology from Arcturus Therapeutics to develop new respiratory vaccines. Still, McKenzie expressed optimism in the overall stability of the U.S. influenza market. 'We are encouraged by the recent positive universal recommendation by the [Advisory Committee on Immunization Practices], a clear sign that influenza is not going away, and it still has severe impact on public health,' he said. The Centers for Disease Control and Prevention currently recommends flu vaccination for all people over the age of 6 years. However, the ACIP panel, newly remade by Kennedy, also recommended for removal of the controversial preservative thimerosal from all flu vaccines. Very few vaccines in the U.S. contain thimerosal, but two multi-dose formulations made by CSL Seqirus do. The job and spending cuts, along with the separation, are expected to save as much as $550 million over the next three years. CSL said it aims to 'balance the reinvestment of these savings in high priority opportunities.' CSL also said it would buy back A$750 million, or about $486 million, of shares this financial year. Shares for CSL fell by over 15% on the Australian stock exchange following announcement of the restructuring. Recommended Reading Ovid partners with Waksal startup to develop drugs for rare brain disorders
Yahoo
13 hours ago
- Yahoo
Experts alarmed as dead turtles with bleeding eyes wash up on Australia's beaches: ‘It's very, very worrying'
More than 32 turtles, some with bleeding eyes, have been found washed up on shores across New South Wales (NSW) in Australia, prompting conservationists to launch an urgent investigation. NSW's National Parks and Wildlife Services said they investigating the deaths of at least 32 turtles that have been found dead across the Port Stephens Council area. Marine rescue group Sea Shelter said it had recorded 25 green turtle deaths at Port Stephens in the past month, including seven in the past week alone. Green turtles are listed as vulnerable under Australian conservation law. The animals have been found at several popular swimming spots, including Shoal Bay, Nelson Bay and Corlette. While the deaths appear to be concentrated around tourist beaches, wildlife experts suggested that may simply reflect the higher likelihood of sightings in well-populated areas. Multiple agencies, including NPWS, the Department of Primary Industries and the Taronga Zoo's Australian Registry of Wildlife Health, are involved in the investigation, according to the Australian Broadcasting Cooperation. 'It's definitely very, very worrying,' Lia Pereira, co-founder of Sea Shelter, told ABC. 'In my personal history of working with turtles, I have never seen this in Port Stephens.' Ryan Pereira, another founder of Sea Shelter in Anna Bay, said they witnessed an increase in the number of sick or dead turtles after recent flooding in the area. He said there were 'too many possibilities at the moment' to confirm the cause of the turtles' deaths. Conservationists said bleeding around the eyes was an unusual symptom. The Taronga Zoo registry said: "A thorough, multifaceted investigation is underway and it may take some weeks to determine the factors contributing to the event." It said they have taken two samples from two dead turtles and are also running diagnostic testing on samples from another 15 turtles from Port Stephens. Earlier this year, more than 400 endangered sea turtles were found washed ashore on India's east coast in an event not witnessed in over two decades. The Olive Ridley turtles, which travel thousands of miles searching for ideal nesting conditions, likely died due to large fishing nets that trawl the ocean floor, experts said.

Associated Press
2 days ago
- Associated Press
Australia's Top Healthcare IT Vendors Named by Black Book Research in 2025 Annual User Rankings
Live results announced today in Melbourne at HIC 2025, Australia's largest digital health and health informatics industry gathering MELBOURNE, AU / ACCESS Newswire / August 18, 2025 / Black Book Research today announced the 2025 top-rated healthcare IT vendors in Australia, recognizing leaders across 13 categories of digital health and hospital information systems. The results were unveiled live at the HIC 2025 conference and on the event website, as more than 1,500 healthcare leaders, clinicians, and technology suppliers gather at the Melbourne Convention and Exhibition Centre. The annual survey drew 864 validated responses from executives, clinicians, and IT leaders across 520 public and 344 private hospitals, representing a broad spectrum of Australia's health sector. Vendors were rated across 18 performance indicators. 2025 Top Vendors by Category - Australia Key Findings Australia's Public hospitals ranked Oracle Health, InterSystems, and Microsoft Azure highest for scalability and alignment with national digital health standards. Private hospitals favored Personify Care, CareMonitor, and Episoft for measurable ROI and Australian-focused patient experience improvement. Solventum earned top marks in coding and HIM, reflecting adoption of analytics and automated coding solutions. Salesforce was recognized for leadership in patient relationship management, supporting health cloud and CRM-driven engagement models. Hyland achieved top ratings in enterprise content and document management, particularly in imaging workflows and secure health records. Australian innovators Heidi Health, DC2Vue, and CareMonitor were noted for agility and responsiveness to evolving government digital health priorities. Australian Health IT Trends (Q2-Q3 2025 Update) From the flash survey in July and August 2025, 484 responses by Australian HIT professionals several trends emerged: Survey Confidence & Methodology With 864 hospitals responding, the survey sample represents two-thirds of all Australian inpatient healthcare facilities, providing a 95% confidence level with a margin of error under 3% for national benchmarking. The 2025 Australian Health Information Systems and Digital Health Survey assessed vendor performance across 18 KPIs, including compliance with Australian regulations, interoperability with My Health Record, cybersecurity and uptime, cloud sovereignty and data residency, clinical usability, ROI, sustainability, implementation support, telehealth capabilities, patient engagement outcomes, and delivery integrity. KPIs were weighted by hospital type and vendor category to reflect real-world priorities, ensuring comparability and accuracy. Access the Full Global HIT Report A complimentary copy of the 530-page 2025 Black Book of Global Healthcare IT, including Q3 updates, is available for download at: For additional data or media inquiries, contact: [email protected] or visit About Black Book Research Black Book Research is an independent global healthcare IT benchmarking firm. The company provides impartial, crowd-sourced vendor evaluations free from financial influences, helping hospitals, payers, and governments worldwide make informed technology decisions. Contact InformationPress Office 8008637590 SOURCE: Black Book Research press release